Holen Sie sich die Stockscreener-App
73.00
1.49%
1.04
Handel nachbörslich:
72.10
-0.90
-1.23%
Schlusskurs vom Vortag:
$71.96
Offen:
$71.49
24-Stunden-Volumen:
342.24K
Relative Volume:
0.98
Marktkapitalisierung:
$2.54B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-91.00M
KGV:
-19.89
EPS:
-3.67
Netto-Cashflow:
$-74.38M
1W Leistung:
+7.57%
1M Leistung:
+22.08%
6M Leistung:
+81.35%
1J Leistung:
+52.18%
1-Tages-Spanne:
$70.97
$73.53
1-Wochen-Bereich:
$67.22
$73.53
52-Wochen-Spanne:
$30.82
$73.53
Disc Medicine Inc Stock (IRON) Company Profile
Firmenname
Disc Medicine Inc
Sektor
Branche
Telefon
(617) 674-9274
Adresse
321 ARSENAL STREET, SUITE 101, WATERTOWN
Vergleichen Sie IRON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
73.00 | 2.50B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-11 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-17 | Eingeleitet | Raymond James | Outperform |
| 2023-04-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Eingeleitet | Stifel | Buy |
| 2023-04-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-03-23 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-28 | Eingeleitet | SVB Securities | Outperform |
Alle ansehen
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Using RSI to spot recovery in Disc Medicine Inc.Bond Market & Fast Entry and Exit Trade Plans - newser.com
Disc Medicine stock hits 52-week high at 72.82 USD - Investing.com India
How Disc Medicine Inc. stock performs in interest rate cycles2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
Top chart patterns to watch in Disc Medicine Inc.July 2025 Review & Entry Point Confirmation Signals - newser.com
Backtesting results for Disc Medicine Inc. trading strategiesEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Momentum divergence signals in Disc Medicine Inc. chartExit Point & AI Powered Buy/Sell Recommendations - newser.com
Can Disc Medicine Inc. stock weather global recessionJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
Is Disc Medicine Inc. stock trading near support levelsEarnings Beat & Safe Entry Zone Identification - newser.com
What MACD and RSI say about Disc Medicine Inc.July 2025 Institutional & Safe Capital Investment Plans - newser.com
Kevin Bitterman Sells 18,039 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Price action breakdown for Disc Medicine Inc.Weekly Stock Summary & High Accuracy Investment Entry Signals - newser.com
Tick level data insight on Disc Medicine Inc. volatilityPortfolio Value Summary & Daily Entry Point Alerts - newser.com
Real time social sentiment graph for Disc Medicine Inc.July 2025 Review & Real-Time Market Sentiment Alerts - newser.com
Disc Medicine's (IRON) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Bitterman Kevin, director at Disc Medicine, sells $6.3m in shares - Investing.com Canada
Building trade automation scripts for Disc Medicine Inc.July 2025 PreEarnings & Verified Swing Trading Watchlists - newser.com
Visual trend scoring systems applied to Disc Medicine Inc.2025 Geopolitical Influence & Detailed Earnings Play Alerts - newser.com
Real time pattern detection on Disc Medicine Inc. stockDip Buying & Reliable Entry Point Alerts - newser.com
Quantitative breakdown of Disc Medicine Inc. recent moveQuarterly Earnings Summary & Daily Oversold Bounce Ideas - newser.com
Disc Medicine (NASDAQ:IRON) Sets New 52-Week HighTime to Buy? - MarketBeat
Disc Medicine stock hits 52-week high at 69.38 USD By Investing.com - Investing.com Nigeria
Disc Medicine director Mona Ashiya resigns, board size reduced to eight - Investing.com
Disc Medicine Board Member Mona Ashiya Resigns - TipRanks
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Disc Medicine stock hits 52-week high at 69.38 USD - Investing.com
Identifying reversal signals in Disc Medicine Inc.Market Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Is Disc Medicine Inc. stock cheap at current valuationPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
Developing predictive dashboards with Disc Medicine Inc. data2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Is Disc Medicine Inc. showing signs of accumulation2025 Institutional Moves & Fast Exit and Entry Strategy Plans - newser.com
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is a relief rally coming for Disc Medicine Inc. holdersEarnings Miss & Stock Portfolio Risk Management - newser.com
What momentum shifts mean for Disc Medicine Inc.Weekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
Will Disc Medicine Inc. stock recover after recent dropEarnings Growth Summary & Daily Technical Forecast Reports - newser.com
Should you wait for a breakout in Disc Medicine Inc.2025 Market Outlook & Expert Curated Trade Setups - newser.com
Analyzing Disc Medicine Inc. with risk reward ratio charts2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
A Fresh Look at Disc Medicine’s Valuation After Bitopertin NDA Submission and Positive Phase 2 Data - Yahoo Finance
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP) - Sahm
Disc MedicineBiotech Stock On The Move With Multiple Near-Term Catalysts - RTTNews
Disc Medicine (NASDAQ:IRON) Sets New 1-Year HighHere's Why - MarketBeat
Disc Medicine submits NDA for bitopertin in erythropoietic porphyria By Investing.com - Investing.com Nigeria
Finanzdaten der Disc Medicine Inc-Aktie (IRON)
Umsatz
Nettogewinn
Free Cashflow
ENV
Disc Medicine Inc-Aktie (IRON) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bitterman Kevin | Director |
Oct 07 '25 |
Sale |
68.38 |
18,039 |
1,233,493 |
572,582 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):